HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yohei Fujishima Selected Research

stage-specific embryonic antigen-3 (GL-X)

12/2017Possibility of inhibiting arthritis and joint destruction by SSEA-3 positive cells derived from synovial tissue in rheumatoid arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yohei Fujishima Research Topics

Disease

1Chromosome Aberrations (Chromosome Abnormalities)
01/2022
1Glioblastoma (Glioblastoma Multiforme)
01/2020
1Starvation
01/2020
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2019
1Genomic Instability
10/2018
1Rheumatoid Arthritis
12/2017
1Arthritis (Polyarthritis)
12/2017
1Carcinogenesis
01/2016
1Aneuploidy (Aneuploid)
01/2016
1Neoplasms (Cancer)
01/2016

Drug/Important Bio-Agent (IBA)

2DNA (Deoxyribonucleic Acid)IBA
01/2020 - 01/2016
2Reactive Oxygen Species (Oxygen Radicals)IBA
10/2018 - 01/2016
1Biological ProductsIBA
01/2022
1Small Interfering RNA (siRNA)IBA
01/2020
1lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
01/2020
1Transcription Factors (Transcription Factor)IBA
12/2019
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
10/2018
1stage-specific embryonic antigen-3 (GL-X)IBA
12/2017
1CollagenIBA
12/2017
1Antirheumatic Agents (DMARD)IBA
12/2017